Related Experiment Video
Updated: Dec 17, 2025

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
MicroRNA-133a-5p inhibiting metastatic capacity of renal clear cell carcinoma through regulating MON2
1Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China. suntingdr@163.com.
Objective:
We aimed at analyzing the correlation between microRNA-133a-5p expression and clinical pathological parameters in patients with clear cell renal cell carcinoma (ccRCC) and exploring the mechanism by which microRNA-133a-5p affects the biological behavior of ccRCC cells.
Patients And Methods:
MicroRNA-133a-5p expression in ccRCC tissues and cell lines were examined by quantitative real-time polymerase chain reaction (qRT-PCR), and the relationship between ATG14 expression and clinicopathological parameters of ccRCC patients was analyzed. A control group (NC mimic) and a microRNA-133a-5p overexpression group (microRNA-133a-5p mimic) were set in the ccRCC cell lines ACHN and 786-O, respectively. The impacts of microRNA-133a-5p on the proliferation and invasion of ccRCC cells were evaluated through performing Cell Counting Kit-8 (CCK-8) and transwell tests, respectively. We further explored the interaction between microRNA-133a-5p and its downstream target gene WNK2 by bioinformatics analysis and Luciferase assay.
Results:
Both in ccRCC tissues and cell lines, microRNA-133a-5p showed a significantly reduced expression, which could be used to predict poor prognosis of ccRCC patients. Upregulation of microRNA-133a-5p markedly blunted the proliferation and migratory capacities of HCC cells. Bioinformatics analysis suggested that microRNA-133a-5p can target MON2. In addition, qPCR assay indicated an increased expression of MON2 in ccRCC cell lines and tissues, which was negatively correlated with microRNA-133a-5p. Finally, in vitro cell reverse experiments suggested that overexpression of MON2 counteracted the inhibitory effects of overexpression of microRNA-133a-5p on the proliferation and metastatic capacity of ccRCC.
Conclusions:
This study suggests that the reduced expression of microRNA-133a-5p in ccRCC tissue specimens can predict poor prognosis of ccRCC patients. At the same time, microRNA-133a-5p may suppress the proliferation capacity and metastasis of ccRCC cells by acting on MON2.
Insights
Reduced microRNA-133a-5p expression in clear cell renal cell carcinoma (ccRCC) predicts poor prognosis. This microRNA suppresses ccRCC cell proliferation and metastasis by targeting MON2.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Clear cell renal cell carcinoma (ccRCC) is a significant health concern.
- Understanding the molecular mechanisms underlying ccRCC progression is crucial for developing effective therapies.
- MicroRNAs play vital roles in cancer development and progression.
Purpose of the Study:
- To investigate the correlation between microRNA-133a-5p expression and clinicopathological parameters in ccRCC patients.
- To explore the functional role of microRNA-133a-5p in ccRCC cell biological behavior.
- To elucidate the underlying molecular mechanism of microRNA-133a-5p in ccRCC.
Main Methods:
- Quantitative real-time polymerase chain reaction (qRT-PCR) was used to examine microRNA-133a-5p and MON2 expression in ccRCC tissues and cell lines.
- Cell Counting Kit-8 (CCK-8) and transwell assays were performed to evaluate the effects of microRNA-133a-5p on ccRCC cell proliferation and invasion.
- Bioinformatics analysis and Luciferase assays were employed to identify and validate the downstream target of microRNA-133a-5p.
Main Results:
- MicroRNA-133a-5p expression was significantly reduced in ccRCC tissues and cell lines, correlating with poor prognosis.
- Overexpression of microRNA-133a-5p inhibited the proliferation and migration of ccRCC cells.
- MON2 was identified as a direct target of microRNA-133a-5p, and its expression was inversely correlated with microRNA-133a-5p in ccRCC.
Conclusions:
- Reduced microRNA-133a-5p expression serves as a potential biomarker for predicting poor prognosis in ccRCC patients.
- MicroRNA-133a-5p suppresses ccRCC cell proliferation and metastasis.
- The inhibitory effects of microRNA-133a-5p on ccRCC progression are mediated through its regulation of MON2.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

